StockNews.AI
TNFA
StockNews.AI
8 hrs

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

1. TNF Pharmaceuticals announces a 1-for-100 reverse stock split effective soon.

Stock Split
-32.67%Current Return
VS
+0.34%S&P 500
$0.0908/28 09:26 AM EDTEvent Start
$0.060608/28 04:32 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bearish?

Reverse stock splits can signal financial distress, impacting investor perception negatively. Historical data suggests that stocks underperform post-reverse split, impacting TNFA's price.

How important is it?

The reverse stock split could affect investor confidence and trading activity, influencing stock price. Such measures usually indicate underlying issues, warranting scrutiny from investors.

Why Short Term?

The immediate impact of a reverse split typically affects market sentiment and liquidity issues. Investors may react swiftly to the change in stock structure.

Related Companies

NASDAQ: NVAXNASDAQ: CYCNNASDAQ: CLBS
NEW YORK--(BUSINESS WIRE)---- $TNFA--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that its board of directors has authorized a reverse stock split of the Company's common stock at a ratio of 1 post-split share for every 100 pre-split shares. The Company's common stock will begin trading on a split-adjusted basis upon market open on Tuesday, S.

Related News